[A comprehensive assessment of the phagocytic activity of the blood neutrophils in patients with rubromycosis treated with griseofulvin and nizoral].
The neutrophilic phagocytic activity (absorption and enzymic bactericidal) is intensified in rubromycosis patients treated with nizoral vs. those administered griseofulvin. it is advisable to combine griseofulvin therapy with biogenic stimulants (pyrogenal, aloe, fiBS, vitreous body).
Belukha
U K
UK
Bidrat
M S
MS
Luk'ianova
A S
AS
D001688:Biological Products / Q000627:therapeutic use; D001770:Blood Bactericidal Activity / Q000187:drug effects; D003131:Combined Modality Therapy; D005533:Foot Dermatoses / Q000188:drug therapy / Q000276:immunology; D006118:Griseofulvin / Q000627:therapeutic use*; D006229:Hand Dermatoses / Q000188:drug therapy / Q000276:immunology; D006801:Humans; D007654:Ketoconazole / Q000627:therapeutic use*; D009504:Neutrophils / Q000187:drug effects* / Q000201:enzymology / Q000276:immunology; D014009:Onychomycosis / Q000188:drug therapy / Q000276:immunology*; D010587:Phagocytosis / Q000187:drug effects*; D014008:Tinea Pedis / Q000188:drug therapy / Q000276:immunology*
D001688:Biological Products; D006118:Griseofulvin; D007654:Ketoconazole
Kompleksnaia otsenka fagotsitarnoĭ aktivnosti neĭtrofilov krovi u bol'nykh rubrofitieĭ, lechennykh grizeoful'vinom i nizoralom.